Results 101 to 110 of about 1,618 (156)

Analysis of the CYP21A2 gene pathogenic variants in CAH patients from Surgut using next-generation sequencing (NGS)

open access: yesEgyptian Journal of Medical Human Genetics
Background 21-hydroxylase deficiency is present in 90–95% of cases of congenital adrenal hyperplasia (CAH). Eleven major pathogenic variants account for 93% of all identified variants in the CYP21A2 gene in various clinical forms of the disease.
Natalia Osinovskaya   +8 more
doaj   +1 more source

Long-read sequencing solves complex structure of CYP21A2 in a large 21-hydroxylase deficiency cohort_Supplementary materials

open access: yes
Long-read sequencing solves complex structure of CYP21A2 in a large 21-hydroxylase deficiency cohort_Supplementary ...
Wenjuan Qiu (11161892)   +3 more
core   +1 more source

Reposicionamiento in silico de fármacos: inhibición selectiva y dual de CYP17A1y CYP21A2 para enfermedades relacionadas con andrógenos [PDF]

open access: yes, 2023
"Muchas enfermedades están relacionadas con las hormonas sexuales esteroideas, destacando el cáncer de próstata y testicular; el uso de fármacos que inhiben las enzimas responsables de su biosíntesis es el mejor tratamiento.
Galeana Ascencio, Ricardo Alonso
core  

Long-read sequencing solves complex structure of CYP21A2 in a large 21-hydroxylase deficiency cohort_Supplemental Table 1.xlsx

open access: yes
Long-read sequencing solves complex structure of CYP21A2 in a large 21-hydroxylase deficiency cohort_Supplemental Table ...
Wenjuan Qiu (11161892)   +3 more
core   +1 more source

Rare nonclassic type of Congenital adrenal hyperplasia due to 21-hydroxylase deficiency and genotype-phenotypic correlation

open access: yesHeliyon
Objective: To explore the correlation between different CYP21A2 pathogenic gene mutations and clinical phenotypes in Congenital adrenal hyperplasia (CAH) patients.
Yanru Hou, Yian Li, Jiajia Ai, Li Tian
doaj   +1 more source

Three novel CYP21A2 mutations and their protein modelling in patients with classical 21-hydroxylase deficiency from northeastern Iran

open access: yes, 2007
Objective: Congenital adrenal hyperplasia (CAH) refers to a group of autosomal recessive disorders frequently caused by mutations in the steroid 21-hydroxylase gene (CYP21A2). We describe three novel CYP21A2 mutations in CAH patients. Design and methods:
Carlsson, J   +20 more
core   +1 more source

Investigation of CYP21A2 mutations in Turkish patients with 21-hydroxylase deficiency and a novel founder mutation

open access: yes, 2013
Congenital adrenal hyperplasia (CAH) is a group of autosomal recessively inherited disorders characterized by impaired production of adrenal steroids. Approximately 95% of all CAH are caused by mutations of the CYP21A2 that encodes 21-hydroxylase.
Toraman, Bayram   +6 more
core   +1 more source

CYP21A2 p.E238 Deletion as Result of Multiple Microconversion Events: A Genetic Study on an Italian Congenital Adrenal Hyperplasia (CAH) Family

open access: yes, 2013
More than 90\% of congenital adrenal hyperplasia (CAH) cases are associated with mutations in the 21-hydroxylase gene (CYP21A2) in the HLA class III area on the short arm of chromosome 6p21.3.
Mello E   +13 more
core   +1 more source

First case of V281+I172N/V281L CYP21A2 genotype associated with congenital adrenal hyperplasia form. A case report from South Italy

open access: yes, 2007
To report a first case of 21-hydroxylase deficiency associated with a new genotype determined by V281+I172N/V281L mutations of the CYP21A2 ...
CORSELLO SM   +26 more
core   +1 more source

Comprehensive Genetic Testing of CYP21A2

open access: yes
The most common form of congenital adrenal hyperplasia (CAH) results from a deficiency of the 21-hydroxylase enzyme (21-OHD), presenting with a broad spectrum of clinical phenotypes according to the CYP21A2 gene mutations. Of the 59 patients with suspected CAH, 62.7% presented a positive genetic result.
Nan, Madalina Nicoleta||   +12 more
openaire   +1 more source

Home - About - Disclaimer - Privacy